2013
DOI: 10.1016/s1262-3636(13)71892-5
|View full text |Cite
|
Sign up to set email alerts
|

P1146 Pharmacocinétique (PK) et pharmacodynamique (PD) à l’état d’équilibre du nouvel analogue lent de l’insuline LY2605541 en administration quotidienne (QD) chez des patients diabétiques de type 2 (DT2) - presented at American Diabetes Association (ADA) 2012 - permission copyright ADA

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles